Royal Bank Of Canada Cardiovascular Systems Inc Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$13.31 - $19.86 $2.88 Million - $4.29 Million	-216,139 Reduced 82.01%	47,425 $941,000
Q4 2022 Feb 14, 2023	BUY	$12.74 - $15.12 $290,981 - $345,340	22,840 Added 9.49%	263,564 $3.59 Million
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $244,493 - $324,667	18,909 Added 8.52%	240,724 $3.34 Million
Q2 2022 Aug 15, 2022	BUY	$13.53 - $23.34 $461,575 - $796,244	34,115 Added 18.18%	221,815 $3.19 Million
Q1 2022 May 16, 2022	BUY	$16.14 - $22.6 $1.43 Million - $2 Million	88,376 Added 88.98%	187,700 $4.24 Million
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $412,633 - $813,977	22,137 Added 28.68%	99,324 $1.87 Million
Q3 2021 Nov 15, 2021	BUY	$32.83 - $43.0 $253,907 - $332,562	7,734 Added 11.14%	77,187 $2.53 Million
Q2 2021 Aug 16, 2021	BUY	$34.41 - $44.03 $2.39 Million - $3.06 Million	69,453 New	69,453 $2.96 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.